Bausch & Lomb, Modulight earn FDA approval for photodynamic laser

Bausch & Lomb and Modulight Corporation, a biomedical laser company, have received approval from the U.S. Food and Drug Administration for its ML6710i photodynamic laser. 

Advertisement

The laser would be used with Bausch & Lomb’s Visudyne, an injectable photosensitizing drug used in photodynamic therapy for patients with subfoveal choroidal neovascularization, or the creation of abnormal choroidal blood vessels, due to age-related macular degeneration. 

The ML6710i laser is transportable and controlled from a mobile app. Its shaping unit can be fit into all common slit lamps for eye examinations. 

It is expected to be available for eye care professionals in 2023.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.